NZ193695A - Pharmaceutical compositions containing n-cyclobutylmethyl-14-hydroxydihydronormorphine (nalbuphine) and n-(4-hydroxyphenyl)-acetamide (acetaminophen) - Google Patents

Pharmaceutical compositions containing n-cyclobutylmethyl-14-hydroxydihydronormorphine (nalbuphine) and n-(4-hydroxyphenyl)-acetamide (acetaminophen)

Info

Publication number
NZ193695A
NZ193695A NZ193695A NZ19369580A NZ193695A NZ 193695 A NZ193695 A NZ 193695A NZ 193695 A NZ193695 A NZ 193695A NZ 19369580 A NZ19369580 A NZ 19369580A NZ 193695 A NZ193695 A NZ 193695A
Authority
NZ
New Zealand
Prior art keywords
nalbuphine
acetaminophen
composition
analgesic
mammal
Prior art date
Application number
NZ193695A
Other languages
English (en)
Inventor
J R Dudzinski
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of NZ193695A publication Critical patent/NZ193695A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ193695A 1979-05-18 1980-05-13 Pharmaceutical compositions containing n-cyclobutylmethyl-14-hydroxydihydronormorphine (nalbuphine) and n-(4-hydroxyphenyl)-acetamide (acetaminophen) NZ193695A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/040,281 US4237140A (en) 1979-05-18 1979-05-18 Analgesic mixture of nalbuphine and acetaminophen

Publications (1)

Publication Number Publication Date
NZ193695A true NZ193695A (en) 1984-05-31

Family

ID=21910135

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ193695A NZ193695A (en) 1979-05-18 1980-05-13 Pharmaceutical compositions containing n-cyclobutylmethyl-14-hydroxydihydronormorphine (nalbuphine) and n-(4-hydroxyphenyl)-acetamide (acetaminophen)

Country Status (12)

Country Link
US (1) US4237140A (enExample)
EP (1) EP0019282B1 (enExample)
JP (1) JPS55154917A (enExample)
AU (1) AU529764B2 (enExample)
CA (1) CA1139671A (enExample)
DE (1) DE3061597D1 (enExample)
HU (1) HU178867B (enExample)
IE (1) IE49988B1 (enExample)
IL (1) IL60095A (enExample)
NZ (1) NZ193695A (enExample)
PH (1) PH15265A (enExample)
ZA (1) ZA802916B (enExample)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322427A (en) * 1981-04-16 1982-03-30 Bristol-Myers Company Analgetic compositions and methods of use
US4366159A (en) * 1981-09-08 1982-12-28 Michael Richard Magruder Nalbuphine-narcotic analgesic composition and method of producing analgesia
US4404210A (en) * 1982-06-30 1983-09-13 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and ibuprofen
US4407804A (en) * 1982-06-30 1983-10-04 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and indomethacin
US4407805A (en) * 1982-06-30 1983-10-04 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and zomepirac
US4404209A (en) * 1982-06-30 1983-09-13 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and sulindac
US4404211A (en) * 1982-06-30 1983-09-13 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and flurbiprofen
US4404208A (en) * 1982-06-30 1983-09-13 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and tiflamizole
AU565634B2 (en) * 1982-06-30 1987-09-24 E.I. Du Pont De Nemours And Company Synergistic compositions of nalbuphine and non-narcotic analgesic compounds
US4402962A (en) * 1982-06-30 1983-09-06 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and 4,5-bis(4-methoxyphenyl)-2-(trifluoromethylsulfonyl)-1H-imidazole
CH659391A5 (de) * 1982-07-22 1987-01-30 Richardson Vicks Inc Koffein enthaltende, analgetische und antiinflammatorische pharmazeutische zubereitung.
US4777174A (en) * 1982-07-22 1988-10-11 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4656177A (en) * 1982-07-22 1987-04-07 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4600579A (en) * 1983-06-07 1986-07-15 Mallinckrodt, Inc. N-acetyl-p-aminophenol compositions containing partially gelatinized starch and method for preparing same
US4722928A (en) * 1985-12-02 1988-02-02 E. I. Du Pont De Nemours And Company N-oxide prodrug derivatives of 3-hydroxy morphinans and partial morphinans having improved oral bioavailability, pharmaceutical compositions, and processes
WO1993004675A1 (en) 1991-09-06 1993-03-18 Mcneilab, Inc. Composition comprising a tramadol material and acetaminophen and its use
US5558876A (en) * 1995-03-29 1996-09-24 Alcon Laboratories, Inc. Topical ophthalmic acidic drug formulations
US6348216B1 (en) * 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
US6277384B1 (en) 1997-12-22 2001-08-21 Euro-Celtique S.A. Opioid agonist/antagonist combinations
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
ES2540103T3 (es) 2000-02-08 2015-07-08 Euro-Celtique S.A. Formulaciones orales de agonistas opioides resistentes a manipulaciones indebidas
CA2446550C (en) 2001-05-11 2012-03-06 Endo Pharmaceuticals, Inc. Abuse-resistant controlled-release opioid dosage form
DK1416842T3 (da) 2001-07-18 2009-03-16 Euro Celtique Sa Farmaceutiske kombinationer af oxycodon og naloxon
PL367427A1 (en) 2001-08-06 2005-02-21 Euro-Celtique S.A. Opioid agonist formulations with releasable and sequestered antagonist
AU2002324624A1 (en) 2001-08-06 2003-02-24 Euro-Celtique S.A. Sequestered antagonist formulations
US20030044458A1 (en) 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
KR100784341B1 (ko) 2002-04-05 2007-12-13 유로-셀띠끄 소시에떼 아노님 활성 화합물의 지속적, 불변적 및 독립적 방출용 매트릭스
EP2422772A3 (en) 2002-09-20 2012-04-18 Alpharma, Inc. Sequestering subunit and related compositions and methods
US20040202717A1 (en) 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
MY135852A (en) 2003-04-21 2008-07-31 Euro Celtique Sa Pharmaceutical products
EP1604666A1 (en) 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
CA2881739C (en) * 2005-08-24 2018-01-02 Endo Pharmaceuticals Inc. Sustained release formulations of nalbuphine
US8394812B2 (en) 2005-08-24 2013-03-12 Penwest Pharmaceuticals Co. Sustained release formulations of nalbuphine
ES2600141T3 (es) 2006-06-19 2017-02-07 Alpharma Pharmaceuticals Llc Composiciones farmacéuticas
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
SMT201900023T1 (it) 2009-03-10 2019-02-28 Euro Celtique Sa Composizioni farmaceutiche a rilascio immediato comprendenti ossicodone e naloxone
WO2015011189A1 (en) 2013-07-23 2015-01-29 Euro-Celtique S.A. A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
SMT202200094T1 (it) 2013-12-24 2022-05-12 Univ Virginia Commonwealth Uso di solfati di colesterolo ossigenati (ocs) per il trattamento dell’insufficienza epatica acuta
JOP20190094A1 (ar) * 2016-10-27 2019-04-25 Broad Inst Inc مركبات 1، 2، 4-تريازولون تحمل ثلاثة بدائل عند المواقع 2، 4، 5 مفيدة كمثبطات لديهيدروجيناز ثنائي هيدرو أوروتات (dhodh)
WO2019070917A1 (en) * 2017-10-03 2019-04-11 The Schepens Eye Research Institute, Inc. COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE DEGENERATION OF RETINAL PIGMENT EPITHELIUM AND METHODS USING SAME
SG11202101974WA (en) * 2018-09-03 2021-03-30 Jacob Biotech Ltd Pharmaceutical preparations of sebacoyl dinalbuphine and acetaminophen and methods for treating pain

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL26896A (en) * 1966-01-19 1970-11-30 Endo Lab 14 - Hydroxynormorphinins and 14 - Hydroxynormorphinones
US4029798A (en) * 1975-06-02 1977-06-14 Sumitomo Chemical Company, Limited Analgetic composition
JPS5946205B2 (ja) * 1976-01-01 1984-11-10 科研製薬株式会社 ベンゾイル誘導体を有効成分とする消炎鎮痛剤

Also Published As

Publication number Publication date
HU178867B (en) 1982-07-28
IL60095A0 (en) 1980-07-31
ZA802916B (en) 1981-12-30
JPH0144684B2 (enExample) 1989-09-29
CA1139671A (en) 1983-01-18
JPS55154917A (en) 1980-12-02
IE49988B1 (en) 1986-01-22
EP0019282A1 (en) 1980-11-26
PH15265A (en) 1982-11-02
DE3061597D1 (en) 1983-02-17
EP0019282B1 (en) 1983-01-12
AU529764B2 (en) 1983-06-16
AU5835180A (en) 1980-11-20
IL60095A (en) 1982-12-31
US4237140A (en) 1980-12-02
IE801019L (en) 1980-11-18

Similar Documents

Publication Publication Date Title
US4237140A (en) Analgesic mixture of nalbuphine and acetaminophen
US5336691A (en) Composition comprising a tramadol material and acetaminophen and its use
Glare et al. Dose-ranging study of oxycodone for chronic pain in advanced cancer.
US5516803A (en) Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
CA2077637C (en) Compositions comprising a tramadol material and any of codeine, oxycodone or hydrocodone and their use
CA1200501A (en) Nalbuphine - narcotic analgesic composition and method of producing analgesia
NO302736B1 (no) Farmasöytisk preparat omfattende tramadol og ibuprofen
US4282215A (en) Analgesic mixture of nalbuphine and acetylsalicylic acid, derivative or salt thereof
US4322427A (en) Analgetic compositions and methods of use
US4260629A (en) Treating pain with acetaminophen and 1,4-dimethyl-5-p-chlorobenzoyl-pyrrole-2-acetic acid
CA2476939A1 (en) Pharmaceutical combinations of cox-2 inhibitors and opiates
TW457087B (en) Pharmaceutical composition for inhibiting dependency and tolerance developed by narcotic analgesic agent
US8148425B2 (en) Pharmaceutical composition containing phloroglucinol and paracetamol
CN101778632B (zh) 综合失调症的治疗或预防药
CA2076149A1 (en) Potentiation of antitussive effect of dextromethorphan
EP0024690B1 (en) Analgesic mixture of nalbuphine and acetylsalicylic acid, derivative or salt thereof
US3218233A (en) Analgesic compositions
WO2018154495A1 (en) Pharmaceutical composition of oral solution of muscarinic antagonist
WO1998058637A1 (en) Acetaminophen and diphenhydramine analgesics
WO1997048390A1 (en) Analgesics combining acetaminophen with meclizine
NZ244507A (en) Pharmaceutical compositions of a tramadol material and acetaminophen